SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that BGI (formerly known as Beijing Genomics Institute) has selected Agilent to streamline and enhance the throughput of BGI’s next generation sequencing workflow. BGI is the largest genome-sequencing facility in Asia and one of the largest genome research centers in the world.